FDA Adverse Event Malfunction Summary report: N

COAGUCHEK® XS SYSTEM

MDR report key: 1854326 · Received October 5, 2010

Report

Report Number
1823260-2010-05899
Event Type
Malfunction
Date Received
October 5, 2010
Date of Event
September 20, 2010
Report Date
October 26, 2010
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Description of Event or Problem · 1

CALLER STATES THE PATIENT TESTED >8.0 INR ON THE COAGUCHEK XS SYSTEM AND 4.07 INR ON A COMPARISON LAB. CALLER STATES THAT THE COUMADIN HAD PREVIOUSLY BEEN HELD FOR ONE DAY. CALLER STATES THAT THE COUMADIN WAS HELD FOR ANOTHER DAY BASED ON THE LAB RESULT. NO OTHER ACTIONS WERE REPORTED TAKEN OR TREATMENT RECEIVED. NO ADVERSE EVENT REPORTED. A REQUEST WAS MADE FOR THE RETURN OF THE AFFECTED PRODUCT.

Description of Event or Problem · 1

A (B)(6) MALE PATIENT UNDERWENT AN ADDITIONAL EVAR PROCEDURE ON (B)(6) 2010. THE PATIENT HAD RECEIVED A ZENITH MAIN BODY WITH ILIAC LIMBS AND OVER TIME ONE OF THE LIMBS SEPARATED CAUSING A TYPE I ENDOLEAK. THE SEPARATION OCCURRED ON THE RIGHT AT THE GRAFT TO LIMB OVERLAP. THE AREA REPRESENTATIVE STATED THAT IT APPEARED THAT THE TORTUOSITY CAUSED THE GRAFT TO PULL BACK LEADING TO THE SEPARATION. TWO ZENITH ILIAC LEG GRAFTS WERE PLACED BEFORE THE INTERNAL ILIAC TO FORM THE LIMB AND SEAL OFF THE ENDOLEAK. THE SECONDARY PROCEDURE SUCCESSFULLY SEALED THE "GAP" AND THE ENDOLEAK WAS NO LONGER PRESENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COAGUCHEK® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS 20180032

Patients

Seq Age Sex Outcome Treatment
1 068 YR COUMADIN (DAILY)| "PERMA-CATH"| NORVASC| LEVEMIR (NIGHTLY)| STOOL SOFTENER (TWICE DAILY)| PROTONIX (DAILY)| MS CONTIN (DAILY)| HYDROCODONE (AS NEEDED)| ALPRAZOLAM (3 TIMES DAILY)